Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinqiao Jingfang Decoction vs Tamiflu for mild influenza A
ChiCTR2300078383Phase 2Recruiting
- Sponsor
- The Affiliated Hospital of Jiaxing University
- Start
- Nov 2023
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of Yin Qiao San in Influenza A infection (2 arms), sponsored by The Affiliated Hospital of Jiaxing University. Primary endpoints: Cure rate and Deterioration rate. Started Nov 2023; status: recruiting.
02
Drugs
Yin Qiao San
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on ChiCTR2300078383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078383.